|
Q4 2022
Filed on Feb 14, 2023
|
16,610
|
$28.68 - $36.71
$476K - $610K
|
|
|
Q4 2022
Filed on Feb 14, 2023
|
503
|
$167.68 - $182.13
$84.3K - $91.6K
|
|
|
Q4 2022
Filed on Feb 14, 2023
|
1,327
|
N/A
|
|
|
Q4 2022
Filed on Feb 14, 2023
|
1,175
|
$6.38 - $11.16
$7.5K - $13.1K
|
|
|
Q4 2022
Filed on Feb 14, 2023
|
11,459
|
$30.08 - $34.91
$345K - $400K
|
|
|
Q4 2022
Filed on Feb 14, 2023
|
26,492
|
$37.31 - $39.75
$988K - $1.05M
|
|
|
Q4 2022
Filed on Feb 14, 2023
|
975
|
$65.03 - $76.96
$63.4K - $75K
|
|
|
Q4 2022
Filed on Feb 14, 2023
|
8
|
$402836.0 - $479086.5
$3.22M - $3.83M
|
|
John Hancock Exchange Traded
|
Q4 2022
Filed on Feb 14, 2023
|
109,618
|
N/A
|
|
|
Q4 2022
Filed on Feb 14, 2023
|
29,142
|
N/A
|
|
|
Q4 2022
Filed on Feb 14, 2023
|
978
|
$88.25 - $103.78
$86.3K - $101K
|
|
|
Q4 2022
Filed on Feb 14, 2023
|
30,796
|
$0.0 - $32.24
$0 - $993K
|
|
|
Q4 2022
Filed on Feb 14, 2023
|
12,000
|
$13.1 - $17.78
$157K - $213K
|
|
|
Q4 2022
Filed on Feb 14, 2023
|
31,486
|
$28.16 - $34.21
$887K - $1.08M
|
|
|
Q4 2022
Filed on Feb 14, 2023
|
353
|
$218.29 - $256.91
$77.1K - $90.7K
|
|
|
Q4 2022
Filed on Feb 14, 2023
|
735
|
$53.99 - $66.65
$39.7K - $49K
|
|
|
Q4 2022
Filed on Feb 14, 2023
|
2,340
|
$71.78 - $89.49
$168K - $209K
|
|
|
Q4 2022
Filed on Feb 14, 2023
|
34,367
|
$23.37 - $25.5
$803K - $876K
|
|
|
Q4 2022
Filed on Feb 14, 2023
|
42,488
|
$16.91 - $19.17
$718K - $814K
|
|
|
Q4 2022
Filed on Feb 14, 2023
|
1,250
|
$203.72 - $248.97
$255K - $311K
|
|
|
Q4 2022
Filed on Feb 14, 2023
|
384
|
$3.34 - $4.38
$1.28K - $1.68K
|
|
|
Q4 2022
Filed on Feb 14, 2023
|
3,500
|
$37.14 - $47.52
$130K - $166K
|
|
|
Q4 2022
Filed on Feb 14, 2023
|
699
|
$45.03 - $55.53
$31.5K - $38.8K
|
|
|
Q4 2022
Filed on Feb 14, 2023
|
571
|
N/A
|
|
|
Q4 2022
Filed on Feb 14, 2023
|
1,414
|
$171.41 - $220.05
$242K - $311K
|
|
|
Q4 2022
Filed on Feb 14, 2023
|
2,400
|
$36.43 - $42.53
$87.4K - $102K
|
|
|
Q4 2022
Filed on Feb 14, 2023
|
4,908
|
$57.18 - $84.9
$281K - $417K
|
|
|
Q4 2022
Filed on Feb 14, 2023
|
235
|
$235.25 - $310.37
$55.3K - $72.9K
|
|
|
Q4 2022
Filed on Feb 14, 2023
|
1,000
|
$142.34 - $165.69
$142K - $166K
|
|
|
Q4 2022
Filed on Feb 14, 2023
|
147,104
|
$11.34 - $12.77
$1.67M - $1.88M
|
|
|
Q4 2022
Filed on Feb 14, 2023
|
722
|
$66.21 - $81.71
$47.8K - $59K
|
|
|
Q4 2022
Filed on Feb 14, 2023
|
674
|
$389.41 - $496.3
$262K - $335K
|
|
|
Q4 2022
Filed on Feb 14, 2023
|
1,225
|
$83.69 - $106.84
$103K - $131K
|
|
|
Q4 2022
Filed on Feb 14, 2023
|
20,285
|
$56.83 - $65.49
$1.15M - $1.33M
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
1,669
|
$137.41 - $154.33
$229K - $258K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
4,097
|
$48.84 - $55.03
$200K - $225K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
3,591
|
$60.55 - $66.68
$217K - $239K
|
|
Alexion Pharmaceuticals Inc
|
Q3 2021
Filed on Nov 12, 2021
|
1,230
|
N/A
|
|
|
Q2 2021
Filed on Aug 16, 2021
|
81
|
$167.25 - $246.31
$13.5K - $20K
|
|
|
Q2 2021
Filed on Aug 16, 2021
|
1,200
|
N/A
|
|
|
Q2 2021
Filed on Aug 16, 2021
|
3,343
|
N/A
|
|
Noble Midstream Partners LP Com Unit Repst
|
Q2 2021
Filed on Aug 16, 2021
|
26,230
|
N/A
|
|
J P Morgan Exchange Traded F
|
Q2 2021
Filed on Aug 16, 2021
|
39,473
|
N/A
|
|
|
Q2 2021
Filed on Aug 16, 2021
|
1,225
|
N/A
|
|
J P Morgan Exchange Traded F
|
Q2 2021
Filed on Aug 16, 2021
|
179,316
|
N/A
|
|
|
Q2 2021
Filed on Aug 16, 2021
|
4,248
|
$6.17 - $12.49
$26.2K - $53.1K
|
|
|
Q1 2021
Filed on May 17, 2021
|
8,304
|
$24.97 - $25.11
$207K - $209K
|
|
|
Q1 2021
Filed on May 17, 2021
|
5,126
|
N/A
|
|
|
Q1 2021
Filed on May 17, 2021
|
4,059
|
N/A
|
|
|
Q1 2021
Filed on May 17, 2021
|
12,614
|
$26.1 - $26.25
$329K - $331K
|
|